Medicure Inc. (OTCMKTS:MCUJF – Get Rating) saw a significant growth in short interest in August. As of August 31st, there was short interest totalling 200 shares, a growth of 100.0% from the August 15th total of 100 shares. Based on an average trading volume of 14,900 shares, the short-interest ratio is presently 0.0 days.
Medicure Price Performance
Shares of OTCMKTS MCUJF remained flat at $0.83 during trading hours on Thursday. The company has a debt-to-equity ratio of 0.03, a current ratio of 1.47 and a quick ratio of 1.16. The firm has a 50 day moving average of $0.80 and a 200-day moving average of $0.84. The company has a market cap of $8.51 million, a P/E ratio of 13.84 and a beta of 0.88. Medicure has a 1-year low of $0.64 and a 1-year high of $1.10.
Get
Medicure alerts:
About Medicure
(Get Rating)
Medicure Inc, a biopharmaceutical company, engages in the research, development, and commercialization of human therapies for the cardiovascular market in Canada and the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction.
See Also
- Get a free copy of the StockNews.com research report on Medicure (MCUJF)
- Why Medical Products Maker Repligen May Be A Potential Buy
- At 10%, Is Arbor Realty Trust Dividend Worth It?
- Investors Should Tune Into RF Industries
- 2 Reasons Netflix Might Have Just Bottomed Out
- Has 3M Reached the Point of Being so Bad It's Good?
Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.
Medicure Inc. (OTCMKTS:MCUJF – Get Rating) saw a significant growth in short interest in August. As of August 31st, there was short interest totalling 200 shares, a growth of 100.0% from the August 15th total of 100 shares. Based on an average trading volume of 14,900 shares, the short-interest ratio is presently 0.0 days.
Medicure Inc.（OTCMKTS: MCUJF — 獲取評級）的空頭利率在8月份大幅增長。截至8月31日，空頭利息總額爲200股，較8月15日的100股總額增長了100.0％。根據14,900股的平均交易量，空頭利率目前爲0.0天。
Medicure Price Performance
Shares of OTCMKTS MCUJF remained flat at $0.83 during trading hours on Thursday. The company has a debt-to-equity ratio of 0.03, a current ratio of 1.47 and a quick ratio of 1.16. The firm has a 50 day moving average of $0.80 and a 200-day moving average of $0.84. The company has a market cap of $8.51 million, a P/E ratio of 13.84 and a beta of 0.88. Medicure has a 1-year low of $0.64 and a 1-year high of $1.10.
在週四的交易時段，OTCMKTS MCUJF的股價持平至0.83美元。該公司的債務與權益比率爲0.03，流動比率爲1.47，速成比率爲1.16。該公司的50天移動平均線爲0.80美元，200天移動平均線爲0.84美元。該公司的市值爲851萬美元，市盈率爲13.84，beta值爲0.88。Medicure的1年低點爲0.64美元，爲1年來的最高水平，爲1.10美元。
Get
Medicure
alerts:
About Medicure
Medicure Inc, a biopharmaceutical company, engages in the research, development, and commercialization of human therapies for the cardiovascular market in Canada and the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction.
Medicure Inc是一家生物製藥公司，從事加拿大和美國心血管市場人體療法的研究、開發和商業化。該公司銷售和分銷 EGRANSTAT 注射劑，這是一種糖蛋白 GP iib/IIIa 受體拮抗劑，用於治療急性冠脈綜合徵，包括不穩定型心絞痛和非 Q 波心肌梗死。
See Also
- Get a free copy of the StockNews.com research report on Medicure (MCUJF)
- Why Medical Products Maker Repligen May Be A Potential Buy
- At 10%, Is Arbor Realty Trust Dividend Worth It?
- Investors Should Tune Into RF Industries
- 2 Reasons Netflix Might Have Just Bottomed Out
- Has 3M Reached the Point of Being so Bad It's Good?
- 免費獲取 StockNews.com 關於 Medicure 的研究報告 (MCUJF) 的副本
- 爲甚麼醫療產品製造商 Repligen 可能成爲潛在買家
- Arbor Realty Trust 的股息爲 10% 值得嗎？
- 投資者應關注射頻行業
- Netflix 可能剛剛觸底的 2 個原因
- 3M 已經到了這麼糟糕以至於很好的地步了嗎？
Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.
接收 Medicure Daily 的新聞和收視率 -在下面輸入您的電子郵件地址，以通過Marketbeat.com的免費每日電子郵件時事通訊接收Medicure及相關公司最新新聞和分析師評級的簡明每日摘要。
